Wuhan Hiteck Biological PharmaLtd Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 17 shareholders own 48.63% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
30.6%	Wuhan Sanjiangyuan Investment Development Co., Ltd.	40,000,000	CN¥1.0b	0%	no data
8.44%	Ya Chen	11,050,000	CN¥276.4m	0%	no data
2.29%	Hubei Linghang Trade Co., Ltd.	3,000,000	CN¥75.0m	0%	no data
2.29%	Hong Wu	3,000,000	CN¥75.0m	0%	no data
1.71%	Nuode Asset Management Co., Ltd.	2,234,803	CN¥55.9m	0%	0.32%
0.88%	UBS Asset Management AG	1,156,385	CN¥28.9m	0%	no data
0.72%	Jingmen High-Tech Industrial Development Co. Ltd	937,500	CN¥23.4m	0%	no data
0.55%	Jie Yan	723,000	CN¥18.1m	-24.9%	no data
0.53%	China Asset Management Co. Ltd.	687,350	CN¥17.2m	0%	no data
0.5%	Changsha Hi-tech Weide Fund Management Co., Ltd.	656,250	CN¥16.4m	0%	100.0%
0.053%	Harvest Fund Management Co. Ltd.	69,500	CN¥1.7m	-17.1%	no data
0.048%	E Fund Management Co., Ltd.	62,700	CN¥1.6m	0%	no data
0.048%	Bosera Asset Management Co., Ltd.	62,582	CN¥1.6m	0%	no data
0.0053%	HFT Investment Management Co. Ltd. (Group)	6,900	CN¥172.5k	0%	no data
0.0037%	China Merchants Fund Management Company Ltd.	4,900	CN¥122.4k	0%	no data
0.0023%	Xingyin Fund Management Co., Ltd.	3,000	CN¥75.0k	0%	no data
0.00015%	Sheng Qiang Li	200	CN¥4.9k	0%	no data